Join to View Full Profile
171 Ashley AveCharleston, SC 29425
Phone+1 843-792-1414
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Eric Meissner, MD is an infectious disease specialist in Charleston, South Carolina. He is currently licensed to practice medicine in South Carolina, Maryland, and Washington.
Education & Training
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2010 - 2013
University of WashingtonResidency, Internal Medicine, 2007 - 2010
University of North Carolina at Chapel Hill School of MedicineClass of 2007
Certifications & Licensure
SC State Medical License 2014 - 2027
MD State Medical License 2011 - 2015
WA State Medical License 2007 - 2011
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
Publications & Presentations
PubMed
- Function of Interferon Lambda Receptor 1 Variants in Stem Cell-Derived Hepatocytes with Abrogated Endogenous.Laura A Novotny, Christiana S Kappler, Eric G Meissner
Journal of Interferon & Cytokine Research. 2025-05-01 - 7 citationsComparison of At-Home Versus In-Clinic Receipt of Long-Acting Injectable Cabotegravir/Rilpivirine.Stephanie E Kirk, Christina Young, Hayley Berry, Rochelle Hanson, Angela Moreland
Clinical Infectious Diseases. 2025-03-17 - 6 citationsExpression and function of interferon lambda receptor 1 variants.Laura A Novotny, Eric G Meissner
FEBS Letters. 2025-02-01
Press Mentions
HMN 2025: How Persons with HIV May Be Handled Safely, Successfully with Long-Acting Antiretroviral Remedy at ResidenceMay 2nd, 2025- Persons Living with HIV Can Be Treated Safely, Effectively with Long-Acting Antiretroviral Therapy at HomeApril 30th, 2025
- Lower Protein Activity After Hepatitis C Therapy May Signal Path to Healing Scarred LiverOctober 26th, 2021
